Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea

Summary

Phase 3 efficacy and safety study of CD07805/47 topical gel in subjects with facial erythema associated with rosacea. The study hypothesis is that CD07805/47 gel, applied topically once daily is more efficacious than vehicle and provides an acceptable safety profile in the treatment of facial erythema associated with rosacea.

Timeline

Start

2011-05

Primary completion

2011-09

Completion

2011-12

Outcome

Met primary endpoint

registry analysis (unspecified test); CD07805/47 Gel vs Placebo; p <0.001; GEE: Logit link function NCT01355458 ↗

Drugs

Indications